Gabapentin recalls

Gabapentin products have been recalled 14 times, most recently on 29 Oct 2025. The recalling company is usually The Harvard Drug Group.

Total recalls14since 2013

Last 12 months1reported

Class I00% of total

Ongoing5latest 29 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 3 0May 0 1 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 8 57%Class III 6 43%

Why gabapentin is recalled

Companies

Product types

Pain Medication14100%

By year

2025536%
202417%
2023214%
2020214%
2015321%
201317%

Ongoing gabapentin recalls

5 active

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 300 mg recalledGabapentin	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 400 mg recalledGabapentin	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS II	Gabapentin Tablets 600mg recalled by Glenmark PharmaceuticalsGabapentin	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide

All gabapentin recalls, newest first

14 total

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 300 mg recalledGabapentin	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 400 mg recalledGabapentin	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS II	Gabapentin Tablets 600mg recalled by Glenmark PharmaceuticalsGabapentin	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
14 Aug 2024Drug	CLASS II	Gabapentin Tablets, USP, 600 mg recalled by Granules PharmaceuticalsGabapentin	Granules Pharmaceuticals	Other	Nationwide
17 May 2023Drug	CLASS III	Gabapentin Tablets, USP 600 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
8 Mar 2023Drug	CLASS III	Gabapentin Tablets, USP 600 mg recalled by Sciegen PharmaceuticalsGabapentin	Sciegen Pharmaceuticals	Other	Nationwide
27 May 2020Drug	CLASS III	Gabapentin Tablets USP, 600 mg recalled by InvaGen PharmaceuticalsGabapentin	InvaGen Pharmaceuticals	Potency & Assay	Nationwide
22 Apr 2020Drug	CLASS II	Gabapentin Capsules, USP 100mg recalled by Aurobindo Pharma USAGabapentin	Aurobindo Pharma USA	Manufacturing (CGMP) Deviations	Nationwide
14 Jan 2015Drug	CLASS II	Gabapentin Capsules, USP 300 mg recalled by Aurobindo Pharma USAGabapentin	Aurobindo Pharma USA	Packaging Defects	Nationwide
14 Jan 2015Drug	CLASS II	Gabapentin Capsules, USP, 100 mg recalled by Actavis ElizabethGabapentin	Actavis Elizabeth	Other	PR
14 Jan 2015Drug	CLASS II	Gabapentin Capsules, USP, 400 mg recalled by Actavis ElizabethGabapentin	Actavis Elizabeth	Other	PR
22 May 2013Drug	CLASS III	Glenmark Gabapentin Tablets, a) 600mg bottle recalledGabapentin	Glenmark Generics Inc. USA	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.